Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone ACetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02703623
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
M.D. Anderson Cancer Center 196
Testing effectiveness (Phase 2)Study completedNCT03458247
What this trial is testing

Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 94
Early research (Phase 1)Study completedNCT01664728
What this trial is testing

An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 54
Early research (Phase 1)Ended earlyNCT01741753
What this trial is testing

BKM120+Abiraterone Acetate for Metastatic CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 4
Large-scale testing (Phase 3)Study completedNCT04887506
What this trial is testing

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-sensitive Prostate CancerMetastatic Prostate Cancer
Tavanta Therapeutics 107
Testing effectiveness (Phase 2)Study completedNCT01088529
What this trial is testing

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Who this might be right for
Prostate Cancer
Cougar Biotechnology, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT03098836
What this trial is testing

Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Daniel George, MD 93
Large-scale testing (Phase 3)Active Not RecruitingNCT04497844
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 696